Powered by healthtechmovers.com
According to healthtechmovers.com, there are a few trending healthtech stocks that have recently received buy ratings and showing positive investor sentiment, as well as news headlines. With that said, the editors over at healthtechmovers.com, are adding the stocks below to their healthtech stock watchlist. That staff here at delrayresearch.com, will continue to monitor these healthtech companies to see if the momentum continues. DelrayResearch.com is also looking into these tickers DAWN, COGT, RMD, BSX, RACE, RTX..
Recent PTCT Stock Price: $43.46
Summary: PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.
Colin Bristow analyst at UBS reiterates coverage on PTC Therapeutics (PTCT) stock in the energy sector with a Hold rating and has set PTCT's stock price target at $ 52.
TipRanks.com reports that PTC Therapeutics currently has 13 analysts offering 12-month price targets on PTCT and the consensus is a Hold rating with an average stock price target of $51.62. The most recent PTCT stock price we have is $43.46 and we are not making any PTCT forecasts at this time.
In addition, TradingView issued a Strong Sell rating for PTCT over the next month, Barchart.com has a Weak buy rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on PTCT. delrayresearch.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on PTCT, please click here >>
Krystal Biotech, KRYS
Recent KRYS Stock Price: $117.39
Summary: Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.
Alec Stranahan analyst at Bank of America Securities reiterates coverage on Krystal Biotech (KRYS) stock in the energy sector with a Buy rating and has set KRYS's stock price target at $ 140.
TipRanks.com reports that Krystal Biotech currently has 8 analysts offering 12-month price targets on KRYS and the consensus is a Strong Buy rating with an average stock price target of $141.00. The most recent KRYS stock price we have is $117.39 and we are not making any KRYS forecasts at this time.
In addition, TradingView issued a Buy rating for KRYS over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on KRYS. delrayresearch.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on KRYS, please click here >>
Mirati Therapeutics, MRTX
Recent MRTX Stock Price: $38.40
Summary: Mirati Therapeutics, Inc. is a clinical-stage biotech developing kinase inhibitors and KRAS inhibitors.
Jay Olson analyst at Oppenheimer reiterates coverage on Mirati Therapeutics (MRTX) stock in the energy sector with a Buy rating and has set MRTX's stock price target at $ 56.
TipRanks.com reports that Mirati Therapeutics currently has 12 analysts offering 12-month price targets on MRTX and the consensus is a Moderate Buy rating with an average stock price target of $61.33. The most recent MRTX stock price we have is $38.40 and we are not making any MRTX forecasts at this time.
In addition, TradingView issued a Strong Sell rating for MRTX over the next month, Barchart.com has a sell rating and Yahoo! Finance has a Bearish short-term outlook. Remember, securities are volatile, so please do your own research on MRTX. delrayresearch.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on MRTX, please click here >>
The editors at delrayresearch.com use a variety of research tools to generate our watchlists and research reports. One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star RankingTM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
Click here to join thousands of investors who have already signed up for a free subscription to consumer staples stocks newsletter PoliticsAndMyPortfolio.com.
==============================================================================
